VASCULAR PHARMACEUTICALS

Company Information

Company Name
VASCULAR PHARMACEUTICALS
Address
1088 KNOLLRIDGE RD
BURLINGTON, NC, 27217-
Phone
n/a
URL
n/a
DUNS
601953974
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
STTR Phase I
$383,173.00
2
STTR Phase II
$1,218,285.00
1
Chart code to be here

Award List

  1. Development of a Novel Method for Inhibiting Atherosclerosis in Diabetes

    Amount: $210,260.00

    DESCRIPTION (provided by applicant): The long term objective of the proposed studies is to develop a monoclonal antibody that can be administered safely to patients with diabetes to determine if it ca ...

    STTR Phase I 2006 Department of Health and Human Services
  2. Development of a Novel Method for Inhibiting Atherosclerosis in Diabetes

    Amount: $1,218,285.00

    DESCRIPTION (provided by applicant): The long term objective of the proposed studies is to develop a monoclonal antibody that can be administered safely to patients with diabetes that will inhibit ath ...

    STTR Phase II 2009 Department of Health and Human Services
  3. Development of a novel method for inhibiting diabetic retinopathy

    Amount: $172,913.00

    DESCRIPTION (provided by applicant): The long-term objective of the proposed study is to develop a monoclonal antibody that inhibits the progression of diabetic retinopathy. Insulin-like growth factor ...

    STTR Phase I 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government